Germany’s Merck KGaA has not appeared near the summit of any rankings on top pharma companies by oncology revenue in recent years, with earnings from its sole c 31 May 2017
Speaking with The Pharma Letter ahead of the upcoming annual meeting of the American Society of Clinical Oncology, Michael Pehl says that: “We are really excite 26 May 2017
Colorectal cancer (CRC) exemplifies the steady progress we’ve made in cancer prevention and treatment.writes Dr Samuel Klempner.director of precision medicine a 25 May 2017
In the run up to the annual meeting of the American Society of Clinical Oncology, we present the first of three analyses focusing on the state of cancer researc 23 May 2017
As the industry’s major players begin to release their curtain raisers, presentation schedules and abstracts ahead of ASCO’s annual meeting, it’s possible to ga 19 May 2017
California-headquartered biotech major Amgen will provide a public update on several key Phase III programs at next month’s annual meeting of the American Socie 19 May 2017
German drugmaker Merck KGaA and US pharma giant Pfizer have promised that 13 abstracts on avelumab across seven hard-to-treat cancers will be presented at this 19 May 2017
No fewer than 20 medicines from Swiss pharma giant Roche will be included in more than 190 abstracts being presented at next month’s 2017 American Society of Cl 12 May 2017
The Pharma Letter's Katie Osborne sums up some of the most exciting research and innovative new cancer treatments presented at this year's annual meeting of the 12 June 2016
Merck & Co (NYSE: MRK) has published updated findings from its Keynote-012 trials for its head and neck cancer drug Keytruda (pembrolizumab). 10 June 2016
A pilot study has shown the huge differences in retail prices of cancer drugs in different countries, and highlighted the burden the cost puts on patients in ma 7 June 2016
US pharma major AbbVie has announced longer-term follow-up results from Phase III studies of Imbruvica (ibrutinib) in chronic lymphocytic leukemia and small lym 7 June 2016
The vice president of the United States Joe Biden has called for greater collaboration across the oncology treatment community in the fight against cancer. 7 June 2016
Germany’s Merck (MRK: DE) and US pharma giant Pfizer (NYSE: PFE) plan to file for accelerated approval of avelumab for the treatment of patients with metastatic 6 June 2016
CHICAGO: Anglo-Swedish drugmaker AstraZeneca has released 'encouraging' early research data for Tagrisso (osimertinib) in patients with leptomeningeal (LM) dise 6 June 2016
US pharma major Bristol-Myers Squibb has presented new data on Opdivo (nivolumab) in fighting lung cancer and on its use with Yervoy (ipilimumab) in advanced me 6 June 2016
Swiss pharma giant Roche has presented Phase II data showing that Tecentriq (atezolizumab) shrank tumours in people with previously untreated advanced bladder c 6 June 2016
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.